托西利祖马布通过IL-6R/STAT3/VEGF通路调节巨细胞极化,减轻胆道新血管化的作用
Yuanyuan Tu1, Yang Guo1, Haotian Sun1
1Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, Jiangsu, China.
Heliyon
|March 25, 2024
概括
托西利祖马布 (TCZ) 通过抑制STAT3/VEGF通路,减少小鼠的胆道新血管化 (CNV). 这项研究揭示了TCZ.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 与年龄相关的黄斑变性 (AMD) 会导致不可逆转的视力丧失,而胆管新血管化 (CNV) 是一个关键因素.
- 互白素-6 (IL-6) /IL-6受体 (IL-6R) 途径与CNV病变发生有关.
- 托西利祖马布 (TCZ) 是一种IL-6R抑制剂,具有潜在的抗炎和抗新血管化作用,但其在CNV中的作用尚不清楚.
研究的目的:
- 调查托西利祖马布 (TCZ) 对冠状动脉新血管化 (CNV) 的治疗作用和潜在机制.
- 探索TCZ对巨细胞极化和STAT3 / VEGF信号通路在CNV.小鼠模型中的影响.
主要方法:
- 激光诱导的CNV小鼠模型被用于评估TCZ治疗.
- 量化了CNV损伤面积和泄漏情况.
- 分析了炎症和巨细胞标记物的基因表达.
- 评估了STAT3/VEGF通路的激活和STAT3激动剂 (Colivelin) 的作用.
主要成果:
- 在小鼠中,TCZ的使用显著减少了中枢神经瘤损伤面积和泄漏.
- 在TCZ调节的巨细胞极化标记物 (iNOS,CCL-3,CCL-5,TNF-α,Arg-1,IL-10,YM-1,CD206) 中.
- TCZ抑制了STAT3/VEGF通路,而这种效果被Colivelin逆转.
结论:
- 通过抑制STAT3/VEGF轴,TCZ通过调节巨细胞极化来减轻CNV的形成和泄漏.
- TCZ显示出作为治疗NV的治疗策略的潜力.
- 用TCZ准IL-6R通路为管理新血管AMD提供了一种新的方法.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523


